8 August 2024
Concurrent Technologies Plc (the “Company” or the “Group”) Concurrent Technologies secures contract expansion with major US Defence and Aerospace contractor Concurrent Technologies Plc (AIM:…
ASSURA PLC ANNOUNCES ACQUISITION OF UK PRIVATE HOSPITAL PORTFOLIO FOR £500M FROM NORTHWEST HEALTHCARE PROPERTIES REIT The Board of Assura plc (“Assura“, the “Company” or “Group“) (the “Board“)…
ALLIANZ TECHNOLOGY TRUST PLC HALF-YEARLY FINANCIAL REPORT For the six months ended 30 June 2024 HIGHLIGHTS · Net Asset Value total return of 28.0% and…
7 August 2024
NETCALL PLC (“Netcall”, the “Company” or the “Group”) Acquisition of Govtech Holdings Limited Extending Local Government footprint and enhancing Liberty portfolio with innovative digital solutions…
GOODWIN PLC PRELIMINARY ANNOUNCEMENT FOR RELEASE ON 7TH AUGUST 2024 Goodwin PLC today announces its preliminary results for the year ended 30th April, 2024….
6 August 2024
Hargreaves Services plc (“Hargreaves”, the “Company”, or the “Group”) Results for the year ended 31 May 2024 Hargreaves Services plc (AIM: HSP), a diversified group…
Statement: Zantac (ranitidine) litigation – Joiner case · Jury in Joiner case in Illinois state court finds GSK not liable for plaintiff’s colorectal cancer · Verdict is consistent…
2 August 2024
US FDA expands Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment…